According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Oric Pharmaceuticals Inc. (ORIC) has announced the launch of an equity offering plan.
Show original
The company will authorize the underwriter Jefferies to periodically issue common stock to the market at appropriate times in the future, with a total fundraising scale of up to $200 million. Such "shelf offering" arrangements provide listed companies with flexible financing channels, allowing them to issue shares in batches according to market conditions and funding needs. This financing plan will support Oric Pharmaceuticals in advancing its pipeline of targeted oncology therapies. By appointing Jefferies as the sales agent, the company can more efficiently seize market windows and optimize its financing structure.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreROMAN DBDR ACQUISITION CORP II recently disclosed that, through a price-based earnout mechanism, the company’s transaction value is expected to achieve significant growth.
TransMedics Group (TMDX) recently provided additional disclosure regarding the specific impact of the release of the deferred tax asset valuation allowance in relation to its previously announced fourth-quarter financial results.
Crypto prices
More
Bitcoin
BTC
$65,960.7
-3.26%
Ethereum
ETH
$1,963.88
-4.94%
Tether USDt
USDT
$1
-0.01%
XRP
XRP
$1.38
-3.91%
BNB
BNB
$615.75
-1.53%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$83.32
-4.65%
TRON
TRX
$0.2846
-0.64%
Dogecoin
DOGE
$0.09518
-3.72%
Cardano
ADA
$0.2831
-2.55%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now